Vaskepa has been available to "medical tourists" in Hainan island since early 2021....Vaskepa has already been used by a large enough number Chinese residents to allow government officials to have a a good appraisal of the risks and benefits of the drug...The remaining question to be resolved now is the cost to the government for supplying Vaskepa to mainland Chinese patients...vs.the cost of CVD to the nation.